Search research articles
Contact Us
Filters
Showing results (91-100 of 138) with videos related to
Page
of 14
Sort By:
Journal of Clinical Medicine
|
April 13, 2024
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study
Teresa Battista, Lucia Gallo, Fabrizio Martora, et al.
Clinical, Cosmetic and Investigational Dermatology
|
December 11, 2023
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
Matteo Megna, Angelo Ruggiero, Antonia Salsano, et al.
Clinical, Cosmetic and Investigational Dermatology
|
January 29, 2024
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical, Cosmetic and Investigational Dermatology
|
August 10, 2023
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
Luca Potestio, Elisa Camela, Sara Cacciapuoti, et al.
Pathology, Research and Practice
|
January 13, 2023
Granuloma annulare after SARS-CoV-2 vaccination: A case report and a literature review
Daniela Russo, Rossella Accarino, Silvia Varricchio, et al.
Clinical, Cosmetic and Investigational Dermatology
|
January 26, 2023
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
Fabrizio Martora, Matteo Megna, Teresa Battista, et al.
Dermatologic Therapy
|
September 2, 2021
Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis
Maddalena Napolitano, Marianna Maffei, Cataldo Patruno, et al.
Expert Opinion on Drug Safety
|
October 13, 2021
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
Alessia Villani, Sonia Sofia Ocampo-Garza, Luca Potestio, et al.
Expert Opinion on Pharmacotherapy
|
June 25, 2024
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Antonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Life (Basel, Switzerland)
|
August 29, 2024
Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris
Luca Potestio, Michela D'Agostino, Antonio Portarapillo, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 138) with videos related to
Sort By:
Page
of 14
Journal of Clinical Medicine
|
April 13, 2024
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study
Teresa Battista, Lucia Gallo, Fabrizio Martora, et al.
Clinical, Cosmetic and Investigational Dermatology
|
December 11, 2023
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
Matteo Megna, Angelo Ruggiero, Antonia Salsano, et al.
Clinical, Cosmetic and Investigational Dermatology
|
January 29, 2024
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical, Cosmetic and Investigational Dermatology
|
August 10, 2023
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
Luca Potestio, Elisa Camela, Sara Cacciapuoti, et al.
Pathology, Research and Practice
|
January 13, 2023
Granuloma annulare after SARS-CoV-2 vaccination: A case report and a literature review
Daniela Russo, Rossella Accarino, Silvia Varricchio, et al.
Clinical, Cosmetic and Investigational Dermatology
|
January 26, 2023
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
Fabrizio Martora, Matteo Megna, Teresa Battista, et al.
Dermatologic Therapy
|
September 2, 2021
Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis
Maddalena Napolitano, Marianna Maffei, Cataldo Patruno, et al.
Expert Opinion on Drug Safety
|
October 13, 2021
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
Alessia Villani, Sonia Sofia Ocampo-Garza, Luca Potestio, et al.
Expert Opinion on Pharmacotherapy
|
June 25, 2024
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Antonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Life (Basel, Switzerland)
|
August 29, 2024
Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris
Luca Potestio, Michela D'Agostino, Antonio Portarapillo, et al.
Page
of 14